IOVANCE BIOTHERAPEUTICS, INC. Cash and Cash Equivalents
IOVANCE BIOTHERAPEUTICS, INC. (IOVA) had Cash and Cash Equivalents of $110.77 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments › Cash and Cash Equivalent
us-gaap:CashAndCashEquivalentsAtCarryingValue · last filed 2026-08-06
- 2026-06-30: Cash and Cash Equivalents, at Carrying Value $110.77M.
- 2026-03-31: Cash and Cash Equivalents, at Carrying Value $196.51M.
- 2025-12-31: Cash and Cash Equivalents, at Carrying Value $163.08M.
- 2025-09-30: Cash and Cash Equivalents, at Carrying Value $158.13M.
| Period end | Cash and Cash Equivalents, at Carrying Value | Cash and Cash Equivalents, at Carrying Value as first filed |
|---|---|---|
| 2026-06-30 | $110.77M 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $196.51M 10-Q · filed 2026-05-07 | |
| 2025-12-31 | $163.08M 10-Q · filed 2026-08-06 | |
| 2025-09-30 | $158.13M 10-Q · filed 2025-11-06 | |
| 2025-06-30 | $132.47M 10-Q · filed 2026-08-06 | |
| 2025-03-31 | $171.67M 10-Q · filed 2026-05-07 | |
| 2024-12-31 | $115.69M 10-K · filed 2026-02-24 | |
| 2024-09-30 | $164.19M 10-Q · filed 2025-11-06 | |
| 2024-06-30 | $228.68M 10-Q · filed 2025-08-07 | |
| 2024-03-31 | $134.19M 10-Q · filed 2025-05-08 | |
| 2023-12-31 | $114.89M 10-K · filed 2026-02-24 | |
| 2023-09-30 | $267.72M 10-Q · filed 2024-11-07 | |
| 2023-06-30 | $230.01M 10-Q · filed 2024-08-08 | |
| 2023-03-31 | $543.48M 10-Q · filed 2024-05-09 | |
| 2022-12-31 | $231.73M 10-K · filed 2025-02-27 | |
| 2022-09-30 | $118.37M 10-Q · filed 2023-11-07 | |
| 2022-06-30 | $108.08M 10-Q · filed 2023-08-08 | |
| 2022-03-31 | $92.36M 10-Q · filed 2023-05-10 | |
| 2021-12-31 | $78.23M 10-K · filed 2024-02-28 | |
| 2021-09-30 | $58.59M 10-Q · filed 2022-11-03 | |
| 2021-06-30 | $82.76M 10-Q · filed 2022-08-04 | |
| 2021-03-31 | $131.95M 10-Q · filed 2022-05-05 | |
| 2020-12-31 | $67.33M 10-K · filed 2023-02-28 | |
| 2020-09-30 | $68.31M 10-Q · filed 2021-11-04 | |
| 2020-06-30 | $160.61M 10-Q · filed 2021-08-05 | |
| 2020-03-31 | $52.54M 10-Q · filed 2021-05-06 | |
| 2019-12-31 | $13.97M 10-K · filed 2022-02-24 | |
| 2019-09-30 | $38.89M 10-Q · filed 2020-11-05 | |
| 2019-06-30 | $76.91M 10-Q · filed 2020-08-06 | |
| 2019-03-31 | $54.09M 10-Q · filed 2020-05-05 | |
| 2018-12-31 | $82.15M 10-K · filed 2021-02-25 | |
| 2018-09-30 | $80.74M 10-Q · filed 2019-11-04 | |
| 2018-06-30 | $246.02M 10-Q · filed 2019-08-01 | |
| 2018-03-31 | $297.08M 10-Q · filed 2019-05-07 | |
| 2017-12-31 | $145.37M 10-K · filed 2020-02-25 | |
| 2017-09-30 | $163.38M 10-Q · filed 2018-11-06 | |
| 2017-06-30 | $114.28M 10-Q · filed 2018-08-07 | |
| 2017-03-31 | $107.10M 10-Q · filed 2018-05-10 | |
| 2016-12-31 | $106.72M 10-K · filed 2019-02-28 | |
| 2016-09-30 | $92.89M 10-Q · filed 2017-11-02 | |
| 2016-06-30 | $120.97M 10-Q · filed 2017-08-03 | $101.22M 10-Q · filed 2016-08-09 |
| 2016-03-31 | $38.91M 10-Q · filed 2017-05-03 | $8.94M 10-Q · filed 2016-05-09 |
| 2015-12-31 | $33.59M 10-K · filed 2019-02-28 | $13.64M 10-K · filed 2016-03-11 |
| 2015-09-30 | $30.77M 10-Q · filed 2016-11-04 | $10.21M 10-Q · filed 2015-11-06 |
| 2015-06-30 | $12.56M 10-Q · filed 2016-08-09 | $12.56M 10-Q · filed 2015-08-10 |
| 2015-03-31 | $111.28M 10-Q · filed 2016-05-09 | $111.28M 10-Q · filed 2015-05-11 |
| 2014-12-31 | $44.91M 10-K · filed 2018-03-12 | $44.91M 10-K · filed 2015-03-16 |
| 2014-09-30 | $17.19M 10-Q · filed 2015-11-06 | $17.19M 10-Q · filed 2014-11-13 |
| 2014-06-30 | $18.44M 10-Q · filed 2015-08-10 | |
| 2014-03-31 | $17.94M 10-Q · filed 2015-05-11 | |
| 2013-12-31 | $19.67M 10-K · filed 2017-03-09 | $19.67M 10-K · filed 2014-03-28 |
| 2013-09-30 | $129.80K 10-Q · filed 2014-11-13 | |
| 2013-06-30 | $569.58K 10-Q · filed 2014-08-08 | $569.58K 10-Q · filed 2013-10-23 |
| 2013-03-31 | $0.00 10-Q · filed 2013-10-23 | |
| 2012-12-31 | $0.00 10-K · filed 2016-03-11 | |
| 2012-09-30 | $0.00 10-Q · filed 2013-01-25 | |
| 2012-06-30 | $15.54K 10-Q · filed 2013-10-23 | $15.74K 10-Q/A · filed 2012-09-10 |
| 2012-03-31 | $0.00 10-Q · filed 2013-10-23 | |
| 2011-12-31 | $510.22K 10-K · filed 2014-03-28 | |
| 2011-09-30 | $128.36K 10-Q · filed 2013-01-25 | $910.61K 10-Q · filed 2011-11-21 |
| 2011-06-30 | $268.56K 10-Q/A · filed 2012-09-10 | $268.56K 10-Q/A · filed 2011-09-01 |
| 2011-03-31 | $722.99K 10-Q · filed 2012-05-15 | |
| 2010-12-31 | $1.29M 10-K · filed 2013-09-23 | |
| 2010-09-30 | $795.94K 10-Q · filed 2011-11-21 | |
| 2010-06-30 | $209.26K 10-Q/A · filed 2011-09-01 | |
| 2009-12-31 | $8.26K 10-K · filed 2012-03-30 | |
| 2008-12-31 | $2.90K 10-K · filed 2012-03-30 | |
| 2007-12-16 | $0.00 10-K · filed 2014-03-28 | |
| 2007-09-16 | $0.00 10-Q · filed 2013-10-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Adaptive Biotechnologies Corp (ADPT) | United States | $4.719B | -53.43 |
| CRISPR Therapeutics AG (CRSP) | $5.390B | -11.68 | |
| Relay Therapeutics, Inc. (RLAY) | United States | $3.884B | -14.30 |
| Scholar Rock Holding Corp (SRRK) | United States | $5.920B | -16.37 |
| CG Oncology, Inc. (CGON) | United States | $6.095B | -27.95 |
| Tarsus Pharmaceuticals, Inc. (TARS) | United States | $3.329B | -58.60 |
| Denali Therapeutics Inc. (DNLI) | United States | $3.274B | -8.04 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Greenland Mines Ltd (GRML) | United States | $2.362B |